Last edition
News about Regulation
USFDA Conducts Pre-Market Inspection at Pashamylaram Facility of Gland Pharma
The Company is committed to address the observations and will submit its response to USFDA within the stipulated time.
Regulation | 28/08/2023 | By Manvi | 745
Gland Pharma Receives EIR From USFDA For Dundigal Facility
Gland Pharma shares gained nearly 3 percent in trade after receiving EIR.
Regulation | 25/08/2023 | By Manvi | 906
Torrent Pharmaceuticals Receives EIR from USFDA for Dahej Facility
The Dahej facility was placed under OAI by the USFDA based on the March 2019 Inspection outcome.
Regulation | 25/08/2023 | By Manvi | 1752
Glenmark Pharma settles drug pricing case with US Department of Justice
Glenmark Pharma settles drug pricing case with US Department of Justice
Regulation | 24/08/2023 | By Sudeep Soparkar | 789
Regulation | 22/08/2023 | By Sudeep Soparkar | 780
Flawless Pharma Pvt Ltd will spend USD 100 Million in Hong Kong and China Assets & Patents buyout
Flawless Pharma Pvt Ltd will spend USD 100 Million in Hong Kong and China Assets & Patents buyout
Regulation | 03/08/2023 | By Sudeep Soparkar | 1156
Lupin Announces Resolution of US FDA Warning Letter for its Goa and Pithampur Facilities
This is after the satisfactory evaluation of the corrective actions taken by the company in response to the Warning Letter that was issued on November 6, 2017.
Regulation | 28/07/2023 | By Manvi | 971
Income Tax Survey at Ipca Laboratories Ltd's plants
The Income Tax Department has carried out survey proceedings at the Company's offices in Mumbai and at Sikkim manufacturing plants between 30th May, 2023 to 3rd June, 2023.
Regulation | 06/06/2023 | By Sudeep Soparkar | 664
US FDA Conducts GMP Inspection at Piramal Pharma's Digwal Facility
The inspection that was held from March 27 to 31 was completed successfully with Zero Form-483 observations.
Regulation | 05/04/2023 | By Manvi | 1635
Govt Cancels License of 18 Pharma Companies
As many as 76 pharma companies were inspected across 20 states/ UTs by a joint team of the state and central drug regulators.
Regulation | 05/04/2023 | By Manvi | 672
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy